Mixed
Weight loss of 20% or higher with newer GLP-1RAs raises concerns for nutritional deficiency and sarcopenia, necessitating monitoring similar to post-bariatric surgery care.
If you are losing a lot of weight (20% or more) on a GLP-1RA, ask your doctor about monitoring for nutritional deficiencies and muscle loss. You may need a dietitian to help you ensure you are getting enough protein and nutrients, similar to post-bariatric surgery guidelines.
With weight loss of 20% or higher with newer GLP-1RAs, nutritional deficiency and sarcopenia are also potential concerns. A multidisciplinary approach including dietetic and psychological assessment as seen in post-bariatric surgery care may be a useful guide to management.
Why this rating
The paper identifies it as a 'potential concern' based on the magnitude of weight loss, drawing parallels to bariatric surgery outcomes.
Source
Opportunities to optimize lifestyle interventions in combination with <scp>glucagon‐like peptide</scp> ‐1‐based therapy
Satya Dash · Diabetes Obesity and Metabolism · 2024
DOI 10.1111/dom.15829
More from this paper
- Newer GLP-1RAs achieve average weight loss of 15% or greater, but a substantial number of patients fail to achieve even 5% weight loss, and weight loss is lower in older adults, males, and those with type 2 diabetes.Good
- Lifestyle interventions (diet and exercise) combined with GLP-1 receptor agonists (GLP-1RAs) may mitigate gastrointestinal side effects and enhance weight loss, though their efficacy requires confirmation via randomized controlled trials.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →